FDA Approves a New PARP Inhibitor for BRCA-mutant Breast Cancer
In the midst of Breast Cancer Awareness Month, the US. Food and Drug Administration (FDA) provided good news for...
Category: Policy
In the midst of Breast Cancer Awareness Month, the US. Food and Drug Administration (FDA) provided good news for...
Last week saw a flurry of new anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) for...
In 2017, electronic cigarettes (e-cigarettes) were the most commonly used tobacco product among high and middle school students. Many...
In the midst of the dog days of summer, the U.S. Food and Drug Administration (FDA) has provided good...
During the early part of summer 2018, the U.S. Food and Drug Administration (FDA) has approved several new anticancer...
Policymakers, parents, teachers, and public health professionals have all expressed concern about the rise in teen vaping and a...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which pembrolizumab...
This week, President Trump signed the Childhood Cancer Survivorship, Treatment, Access and Research (STAR) Act, which is aimed at...
On May 4, the U.S. Food and Drug Administration (FDA) approved a combination of molecularly targeted therapeutics for the...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved expanding the use of the immunotherapeutic tisagenlecleucel (Kymriah)...